These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20571276)

  • 21. Resection of isolated liver oligometastatic disease in pancreatic ductal adenocarcinoma: Is there a survival benefit? A systematic review.
    Halle-Smith JM; Powell-Brett S; Roberts K; Chatzizacharias NA
    World J Gastrointest Surg; 2023 Jul; 15(7):1512-1521. PubMed ID: 37555114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Essential updates 2021/2022: Surgical outcomes of oligometastasis in pancreatic ductal adenocarcinoma.
    Yasuda S; Nagai M; Terai T; Kohara Y; Sho M
    Ann Gastroenterol Surg; 2023 May; 7(3):358-366. PubMed ID: 37152775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver metastasis of pancreatic cancer: the new choice at the crossroads.
    Liu Z; Gou A; Wu X
    Hepatobiliary Surg Nutr; 2023 Feb; 12(1):88-91. PubMed ID: 36860262
    [No Abstract]   [Full Text] [Related]  

  • 24. Oncologic resection of pancreatic cancer with isolated liver metastasis: Favorable outcomes in select patients.
    Nagai M; Wright MJ; Ding D; Thompson ED; Javed AA; Weiss MJ; Hruban RH; Yu J; Burkhart RA; He J; Cameron JL; Wolfgang CL; Burns WR
    J Hepatobiliary Pancreat Sci; 2023 Aug; 30(8):1025-1035. PubMed ID: 36652559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors and predictive nomograms for early death of patients with pancreatic cancer liver metastasis: A large cohort study based on the SEER database and Chinese population.
    Zhang H; Dong H; Pan Z; Du X; Liu S; Xu W; Zhang Y
    Front Oncol; 2022; 12():998445. PubMed ID: 36212438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Assessment of Liver Metastasis in Pancreatic Cancer Patients Using Multiple Models Based on Machine Learning: A Large Population-Based Study.
    Li Q; Bai L; Xing J; Liu X; Liu D; Hu X
    Dis Markers; 2022; 2022():1586074. PubMed ID: 35634443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Korean Surgical Practice Guideline for Pancreatic Cancer 2022: A summary of evidence-based surgical approaches.
    Lee SE; Han SS; Kang CM; Kwon W; Paik KY; Song KB; Yang JD; Chung JC; Jeong CY; Kim SW;
    Ann Hepatobiliary Pancreat Surg; 2022 Feb; 26(1):1-16. PubMed ID: 35220285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Worth it or not? Primary tumor resection for stage IV pancreatic cancer patients: A SEER-based analysis of 15,836 cases.
    Fu N; Jiang Y; Weng Y; Chen H; Deng X; Shen B
    Cancer Med; 2021 Sep; 10(17):5948-5963. PubMed ID: 34288562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical margin clearance and extended chemotherapy defines survival for synchronous oligometastatic liver lesions of the ductal adenocarcinoma of the pancreas.
    Safi SA; Fluegen G; Rehders A; Haeberle L; Fung S; Keitel V; Krieg A; Knoefel WT; Lehwald-Tywuschik N
    Int J Clin Oncol; 2021 Oct; 26(10):1911-1921. PubMed ID: 34132929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Locoregional Treatment of Metastatic Pancreatic Cancer Utilizing Resection, Ablation and Embolization: A Systematic Review.
    Timmer FEF; Geboers B; Nieuwenhuizen S; Schouten EAC; Dijkstra M; de Vries JJJ; van den Tol MP; Meijerink MR; Scheffer HJ
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33807220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can Patients with Pancreatic Cancer and Liver Metastases Obtain Survival Benefit from Surgery? A Population-Based Study.
    Su BB; Bai DS; Yu JQ; Zhang C; Jin SJ; Zhou BH; Jiang GQ
    J Cancer; 2021; 12(2):539-552. PubMed ID: 33391450
    [No Abstract]   [Full Text] [Related]  

  • 32. Current Role of Surgery in Pancreatic Cancer With Synchronous Liver Metastasis.
    Zhou W; Wang D; Lou W
    Cancer Control; 2020; 27(1):1073274820976593. PubMed ID: 33238715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Concepts for Oligometastatic Gastrointestinal Tumours.
    Ricke J; Westphalen CB; Seidensticker M
    Visc Med; 2020 Oct; 36(5):359-363. PubMed ID: 33178732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastatic pancreatic adenocarcinomas could be classified into M1a and M1b category by the number of metastatic organs.
    Feng F; Cai W; Wang G; Chen W; Yang H; Sun M; Zhou L
    BMC Gastroenterol; 2020 Aug; 20(1):289. PubMed ID: 32854631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical and local treatment of hepatic metastasis in pancreatic ductal adenocarcinoma: recent advances and future prospects.
    Jin T; Dai C; Xu F
    Ther Adv Med Oncol; 2020; 12():1758835920933034. PubMed ID: 32636941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1).
    Wei M; Shi S; Hua J; Xu J; Yu X;
    BMJ Open; 2019 Dec; 9(12):e033452. PubMed ID: 31818843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do Patients Diagnosed with Metastatic Pancreatic Cancer Benefit from Primary Tumor Surgery? A Propensity-Adjusted, Population-Based Surveillance, Epidemiology and End Results (SEER) Analysis.
    Wang L; Yang L; Chen L; Chen Z
    Med Sci Monit; 2019 Nov; 25():8230-8241. PubMed ID: 31677259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality?
    Ghidini M; Petrillo A; Salati M; Khakoo S; Varricchio A; Tomasello G; Grossi F; Petrelli F
    Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31374916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oligometastases in pancreatic cancer (Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis).
    Voss N; Izbicki JR; Nentwich MF
    Ann Gastroenterol Surg; 2019 Jul; 3(4):373-377. PubMed ID: 31346576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgery for Recurrent Pancreatic Cancer: Is It Effective?
    Moletta L; Serafini S; Valmasoni M; Pierobon ES; Ponzoni A; Sperti C
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31315222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.